IP Group’s (IPO) “Buy” Rating Reiterated at Berenberg Bank

IP Group (LON:IPO)‘s stock had its “buy” rating reaffirmed by research analysts at Berenberg Bank in a research report issued on Tuesday, Digital Look reports. They presently have a GBX 119 price objective on the stock. Berenberg Bank’s price target points to a potential upside of 75.00% from the company’s previous close.

IP Group Stock Performance

LON IPO opened at GBX 68 on Tuesday. IP Group has a twelve month low of GBX 48 and a twelve month high of GBX 75. The company has a quick ratio of 8.59, a current ratio of 0.16 and a debt-to-equity ratio of 12.28. The company’s 50-day simple moving average is GBX 67.69 and its 200 day simple moving average is GBX 62.94. The stock has a market cap of £600.73 million, a P/E ratio of 9.58 and a beta of 1.27.

IP Group (LON:IPO) last issued its quarterly earnings data on Tuesday, September 15th. The company reported GBX 3.53 earnings per share (EPS) for the quarter. IP Group had a return on equity of 7.14% and a net margin of 148.78%. As a group, research analysts forecast that IP Group will post 19.6245031 earnings per share for the current fiscal year.

Insider Activity at IP Group

In other news, insider Greg Smith bought 45,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 5th. The shares were acquired at an average price of GBX 68 per share, with a total value of £30,600. Also, insider David Baynes purchased 26,368 shares of the stock in a transaction on Wednesday, August 5th. The stock was acquired at an average price of GBX 68 per share, for a total transaction of £17,930.24. Insiders bought a total of 271,368 shares of company stock worth $18,053,024 in the last quarter. Corporate insiders own 1.57% of the company’s stock.

IP Group Company Profile

IP Group accelerates the impact of science for a better future. As the most active UK based, early-stage science investor, we develop and support some of the world’s most exciting businesses in deeptech, life sciences and cleantech (led by Kiko Ventures). Through Parkwalk, the UK’s largest growth EIS fund manager, we also back world-changing innovation emerging in leading universities and research institutions. Our specialist investment team combines sector expertise with an international approach.